title: Comparative study of the efficacy and tolerability of a unique topical scar product vs white petrolatum following shave biopsies.
abstract: An excess of 70 million cutaneous surgical procedures are conducted annually in the United States that may result in scarring. Skin scars are a normal outcome of the tissue repair process. However, individuals with abnormal scarring may have aesthetic, psychological, and social consequences. As a result, there is a high patient demand for products that will reduce the scarring. The principles underlying scar formation are now better understood. Products are being developed to address those critical components of the wound-healing process, namely inflammation, hydration, and collagen maturation. A multicomponent scar product was previously shown effective in preventing exaggerated scarring in patients undergoing various surgical procedures. The present outpatient study was conducted in patients undergoing shave biopsies. Following reepithelialization, this investigator-blinded, randomized, 8-week trial compared twice-daily application of either the scar product or the standard of care, white petrolatum. Evaluation visits were conducted at baseline and at weeks, 1, 2, 4 and 8. Subjects were evaluated by the blinded investigator for clinical efficacy and tolerability using grading scales. Standardized digital photographs were taken at each visit, and subjects completed a self-assessment questionnaire regarding treatment effectiveness and satisfaction. Twenty-eight subjects completed the 8-week study. The scar product provided earlier improvements than the white petrolatum. At week 1, 70% of subjects receiving the scar product demonstrated at least 50% global improvement in scar appearance vs only 42% of the subjects receiving white petrolatum. The more rapid improvement was accompanied by greater reductions in stinging/burning and itching with the scar product at all visits. Importantly, there was also greater subject satisfaction with the scar product at all visits. This scar product may be useful in hastening the healing of cutaneous shave biopsies and reducing the stinging/burning and itching associated with the normal healing process.
authors: Mount Sinai Medical Center, New York, NY, USA. wedoderm@yahoo.com
authors: Leon H
authors: LH
authors: Kircik
mesh_terms: D000328:Adult; D000368:Aged; D001706:Biopsy; D028041:Centella / Q000737:chemistry; D002921:Cicatrix / Q000188:drug therapy* / Q000473:pathology*; D059026:Diagnostic Self Evaluation; D004311:Double-Blind Method; D004643:Emollients / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D005782:Gels; D006801:Humans; D057888:Iridoid Glucosides; D039823:Iridoids; D008297:Male; D008875:Middle Aged; D010577:Petrolatum / Q000009:adverse effects / Q000627:therapeutic use*; D010936:Plant Extracts / Q000627:therapeutic use; D011537:Pruritus / Q000209:etiology; D011714:Pyrans / Q000627:therapeutic use; D012039:Regional Blood Flow; D012677:Sensation; D012867:Skin / Q000098:blood supply / Q000473:pathology; D012880:Skin Pigmentation; D014665:Vasodilator Agents / Q000627:therapeutic use; D055815:Young Adult
chemical_list: D004643:Emollients; D005782:Gels; D057888:Iridoid Glucosides; D039823:Iridoids; D010936:Plant Extracts; D011714:Pyrans; D014665:Vasodilator Agents; C002769:oleuropein; D010577:Petrolatum